Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CUE

Cue Biopharma Inc

May 07 • 04:00PM ET

35.73

+1.75 5.15 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ATRA IMUX VERU TNXP OCGN

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-9.40	Insider Own	0.56%	Shs Outstand	3.26M	Perf Week	142.40%
Market Cap	116.32M	Forward P/E	-	EPS next Y	-18.00	Insider Trans	-	Shs Float	3.24M	Perf Month	334.99%
Enterprise Value	93.38M	PEG	-	EPS next Q	-	Inst Own	22.31%	Short Float	7.76%	Perf Quarter	276.78%
Income	-26.60M	P/S	4.23	EPS this Y	-107.14%	Inst Trans	-	Short Ratio	0.34	Perf Half Y	65.14%
Sales	27.47M	P/B	4.35	EPS next Y	-3.45%	ROA	-70.62%	Short Interest	0.25M	Perf YTD	289.98%
Book/sh	8.21	P/C	4.29	EPS next 5Y	-	ROE	-121.11%	52W High	41.42 -13.74%	Perf Year	55.00%
Cash/sh	8.34	P/FCF	-	EPS past 3/5Y	42.63% 29.04%	ROIC	-	52W Low	4.97 618.77%	Perf 3Y	-75.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	180.45% 54.16%	Gross Margin	95.89%	Volatility	29.51% 42.15%	Perf 5Y	-89.42%
Dividend TTM	-	EV/Sales	3.40	EPS Y/Y TTM	58.21%	Oper. Margin	-96.56%	ATR (14)	6.24	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.74	Sales Y/Y TTM	195.75%	Profit Margin	-96.85%	RSI (14)	72.13	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.74	EPS Q/Q	111.21%	SMA20	69.70%	Beta	2.52	Target Price	115.00
Payout	-	Debt/Eq	0.16	Sales Q/Q	1292.26%	SMA50	170.44%	Rel Volume	0.58	Prev Close	33.98
Employees	29	LT Debt/Eq	0.09	Earnings	Mar 16 AMC	SMA200	112.90%	Avg Volume	735.78K	Price	35.73
IPO	Jan 02, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	111.11% 2094.20%	Trades		Volume	426,829	Change	5.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)